Stock-Based Compensation Plans (Tables)

9 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of weighted average fair value at date of grant for options

The fair value was estimated based on the weighted average assumptions of:

	For nine months ended March 31,
	2017			2016
Risk-free interest rates		1.80	%		1.71	%
Expected option life in years		6.25			6.25
Expected stock price volatility		54.68	%		55.41	%
Expected dividend yield		0	%		0	%

Schedule of summary of option activity

A summary of option activity under the Company’s equity plans as of March 31, 2017, and changes during the nine months ended March 31, 2017 is presented below:

	Outstanding  Shares			Average Exercise  Price		Aggregate Instrinsic Value
Vested and exercisable at June 30, 2016		1,790,224		$	6.38	$	1,675,072
Granted		327,500		$	8.34
Exercised		(52,500	)	$	5.78
Forfeited		(376,625	)	$	8.24
Expired		(2,700	)	$	3.45
Outstanding as of March 31, 2017		1,685,899		$	6.37	$	9,324,182
Vested and exercisable at March 31, 2017		980,774		$	4.63	$	7,097,409